Fig. 3
From: PDCL3 is a prognostic biomarker associated with immune infiltration in hepatocellular carcinoma
Prognostic relevance of PDCL3 in LIHC. A–C Relationship between PDCL3 expression and patient prognosis in terms of OS (overall survival), DSS (disease-specific survival), and PFS (progression-free survival). D ROC curves for PDCL3 and LIHC prognosis. E–G Time-dependent ROC curves for PDCL3 and LIHC patient prognosis. H Clinical prognostic risk score for PDCL3. I Calibration plot for model accuracy assessment